Investment
Features
FeesSafety
Academy
More
Pluang+

Elemental Royalty declares $0.03 quarterly dividend with option to receive in Tether Gold tokens.

Company Fundamentals
17 Sep 2026
Newsfile Corp
View Source
Bullish
Elemental Royalty declares $0.03 quarterly dividend with option to receive in Tether Gold tokens.

Elemental Royalty Corporation announced a quarterly dividend of $0.03 per common share, totaling $0.12 for fiscal 2026, payable on October 15, 2026. Shareholders can opt to receive dividends in cash or in Tether Gold XAU₮ tokens through a Dividend Election Alternative, requiring election by September 24, 2026. This option involves partnering with Bullish and Equiniti for token distribution, subject to legal and regulatory compliance. The dividend payment method and future dividends remain at the board's discretion, with detailed election procedures and risks outlined on the company's website.

Elemental Royalty Corporation's dividend announcement provides context for readers. For those following Basic Materials, here is Pluang's market snapshot as of Sep 17, 2026 18:11 WIB: 26 of 31 US Basic Materials stocks rose. Agnico Eagle Mines Ltd (AEM) rose 2.04% to USD 199.56 with 100% buy orders. Freeport-McMoRan Inc (FCX) gained 1.86% to USD 70.54 with 57% buy orders. Kinross Gold Corporation (KGC) increased 1.83% to USD 28.33 despite 91% sell orders. Typical hold times range from 52 to 68 days.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
34 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App